Report Detail
Global Biologics and Biosimilars Market Status, Trends and COVID-19 Impact Report 2022
- RnM4505248 |
- 01 February, 2023 |
- Global |
- 121 Pages |
- BisReport |
- Other
Global Biologics and Biosimilars Market Status, Trends and COVID-19 Impact Report 2022
Single User License Report: 2350 USD
Corporate User License Report: 4700 USD
Section Price: As below
Page: 118
Chart and Figure: 150
Publisher: BisReport
Delivery Time: 48 hour
In the past few years, the Biologics and Biosimilars market experienced a huge change under the influence of COVID-19 and Russia-Ukraine War, the global market size of Biologics and Biosimilars reached 209500.0 million $ in 2022 from 176000.0 in 2017 with a CAGR of 0.0354622536182 from 2017-2022. Facing the complicated international situation, the future of the Biologics and Biosimilars market is full of uncertain. BisReport predicts that the global Biologics and Biosimilars market size will reach 261000.0 million $in 2028 with a CAGR of xx% from 2022-2028.
Since the outbreak of COVID-19, the world economy continues to suffer from a series of destabilizing shocks, many companies experienced bankruptcy and a sharp decline in turnover. After more than two years of pandemic, global economy began to recover, entering 2022, the Russian Federation’s invasion of Ukraine and its global effects on commodity markets, supply chains, inflation, and financial conditions have steepened the slowdown in global growth. In particular, the war in Ukraine is leading to soaring prices and volatility in energy markets, with improvements in activity in energy exporters more than offset by headwinds to activity in most other economies. The invasion of Ukraine has also led to a significant increase in agricultural commodity prices, which is exacerbating food insecurity and extreme poverty in many emerging market and developing economies.
Numerous risks could further derail what is now a precarious recovery. Among them is, in particular, the possibility of stubbornly high global inflation accompanied by tepid growth, reminiscent of the stagflation of the 1970s. This could eventually result in a sharp tightening of monetary policy in advanced economies to rein in inflation, lead to surging borrowing costs, and possibly culminate in financial stress in some emerging market and developing economies. A forceful and wide-ranging policy response is required by policy makers in these economies and the global community to boost growth, bolster macroeconomic frameworks, reduce financial vulnerabilities, provide support to vulnerable population groups, and attenuate the long-term impacts of the global shocks of recent years.
In this complex international situation, BisReport published Global Biologics and Biosimilars Market Status, Trends and COVID-19 Impact Report 2022, which provides a comprehensive analysis of the global Biologics and Biosimilars market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type segment, application segment, channel segment etc. historic data period is from 2017-2022, the forecast data from 2023-2028.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Section 4: 900 USD——Region Segment
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Russia, Italy)
Middle East and Africa (Middle East, South Africa, Egypt)
Section (5 6 7): 700 USD——
Product Type Segment
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Application Segment
Tumor
Diabetes
Cardiovascular
Hemophilia
Channel Segment (Direct Sales, Distribution Channel)
Section 8: 500 USD——Market Forecast (2023-2028)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
Table of Contents
Section 1 Biologics and Biosimilars Market Overview
- 1.1 Biologics and Biosimilars Market Scope
- 1.2 COVID-19 Impact on Biologics and Biosimilars Market
- 1.3 Global Biologics and Biosimilars Market Status and Forecast Overview
- 1.3.1 Global Biologics and Biosimilars Market Status 2017-2022
- 1.3.2 Global Biologics and Biosimilars Market Forecast 2023-2028
- 1.4 Global Biologics and Biosimilars Market Overview by Region
- 1.5 Global Biologics and Biosimilars Market Overview by Type
- 1.6 Global Biologics and Biosimilars Market Overview by Application
Section 2 Global Biologics and Biosimilars Market Manufacturer Share
- 2.1 Global Manufacturer Biologics and Biosimilars Sales Volume
- 2.2 Global Manufacturer Biologics and Biosimilars Business Revenue
- 2.3 Global Manufacturer Biologics and Biosimilars Price
Section 3 Manufacturer Biologics and Biosimilars Business Introduction
- 3.1 Roche Biologics and Biosimilars Business Introduction
- 3.1.1 Roche Biologics and Biosimilars Sales Volume, Price, Revenue and Gross margin 2017-2022
- 3.1.2 Roche Biologics and Biosimilars Business Distribution by Region
- 3.1.3 Roche Interview Record
- 3.1.4 Roche Biologics and Biosimilars Business Profile
- 3.1.5 Roche Biologics and Biosimilars Product Specification
- 3.2 Amgen Biologics and Biosimilars Business Introduction
- 3.2.1 Amgen Biologics and Biosimilars Sales Volume, Price, Revenue and Gross margin 2017-2022
- 3.2.2 Amgen Biologics and Biosimilars Business Distribution by Region
- 3.2.3 Interview Record
- 3.2.4 Amgen Biologics and Biosimilars Business Overview
- 3.2.5 Amgen Biologics and Biosimilars Product Specification
- 3.3 Manufacturer three Biologics and Biosimilars Business Introduction
- 3.3.1 Manufacturer three Biologics and Biosimilars Sales Volume, Price, Revenue and Gross margin 2017-2022
- 3.3.2 Manufacturer three Biologics and Biosimilars Business Distribution by Region
- 3.3.3 Interview Record
- 3.3.4 Manufacturer three Biologics and Biosimilars Business Overview
- 3.3.5 Manufacturer three Biologics and Biosimilars Product Specification
- 3.4 Manufacturer four Biologics and Biosimilars Business Introduction
- 3.4.1 Manufacturer four Biologics and Biosimilars Sales Volume, Price, Revenue and Gross margin 2017-2022
- 3.4.2 Manufacturer four Biologics and Biosimilars Business Distribution by Region
- 3.4.3 Interview Record
- 3.4.4 Manufacturer four Biologics and Biosimilars Business Overview
- 3.4.5 Manufacturer four Biologics and Biosimilars Product Specification
- 3.5
- 3.6
…
Section 4 Global Biologics and Biosimilars Market Segment (By Region)
- 4.1 North America Country
- 4.1.1 United States Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.1.2 Canada Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.1.3 Mexico Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.2 South America Country
- 4.2.1 Brazil Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.2.2 Argentina Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.3 Asia Pacific
- 4.3.1 China Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.3.2 Japan Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.3.3 India Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.3.4 Korea Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.3.5 Southeast Asia Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.4 Europe Country
- 4.4.1 Germany Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.4.2 UK Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.4.3 France Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.4.4 Spain Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.4.5 Russia Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.4.6 Italy Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.5 Middle East and Africa
- 4.5.1 Middle East Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.5.2 South Africa Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.5.3 Egypt Biologics and Biosimilars Market Size and Price Analysis 2017-2022
- 4.6 Global Biologics and Biosimilars Market Segment (By Region) Analysis 2017-2022
- 4.7 Global Biologics and Biosimilars Market Segment (By Country) Analysis 2017-2022
- 4.8 Global Biologics and Biosimilars Market Segment (By Region) Analysis
Section 5 Global Biologics and Biosimilars Market Segment (by Product Type)
- 5.1 Product Introduction by Type
- 5.1.1 Monoclonal Antibodies Product Introduction
- 5.1.2 Interferon Product Introduction
- 5.1.3 Erythropoietin Product Introduction
- 5.1.4 Insulin Product Introduction
- 5.1.5 Vaccines Product Introduction
- 5.2 Global Biologics and Biosimilars Sales Volume (by Type) 2017-2022
- 5.3 Global Biologics and Biosimilars Market Size (by Type) 2017-2022
- 5.4 Different Biologics and Biosimilars Product Type Price 2017-2022
- 5.5 Global Biologics and Biosimilars Market Segment (By Type) Analysis
Section 6 Global Biologics and Biosimilars Market Segment (by Application)
- 6.1 Global Biologics and Biosimilars Sales Volume (by Application) 2017-2022
- 6.2 Global Biologics and Biosimilars Market Size (by Application) 2017-2022
- 6.3 Biologics and Biosimilars Price in Different Application Field 2017-2022
- 6.4 Global Biologics and Biosimilars Market Segment (By Application) Analysis
Section 7 Global Biologics and Biosimilars Market Segment (by Channel)
- 7.1 Global Biologics and Biosimilars Market Segment (By Channel) Sales Volume and Share 2017-2022
- 7.2 Global Biologics and Biosimilars Market Segment (By Channel) Analysis
Section 8 Global Biologics and Biosimilars Market Forecast 2023-2028
- 8.1 Biologics and Biosimilars Segment Market Forecast 2023-2028 (By Region)
- 8.2 Biologics and Biosimilars Segment Market Forecast 2023-2028 (By Type)
- 8.3 Biologics and Biosimilars Segment Market Forecast 2023-2028 (By Application)
- 8.4 Biologics and Biosimilars Segment Market Forecast 2023-2028 (By Channel)
- 8.5 Global Biologics and Biosimilars Price (USD/Unit) Forecast
Section 9 Biologics and Biosimilars Application and Customer Analysis
- 9.1 Tumor Customers
- 9.2 Diabetes Customers
- 9.3 Cardiovascular Customers
- 9.4 Hemophilia Customers
Section 10 Biologics and Biosimilars Manufacturing Cost of Analysis
- 10.1 Raw Material Cost Analysis
- 10.2 Labor Cost Analysis
- 10.3 Cost Overview
Section 11 Conclusion
12 Research Method and Data Source
Chart and Figure
Figure Biologics and Biosimilars Product Picture
Chart Global Biologics and Biosimilars Market Size (with or without the impact of COVID-19)
Chart Global Biologics and Biosimilars Sales Volume (Units) and Growth Rate 2017-2022
Chart Global Biologics and Biosimilars Market Size (Million $) and Growth Rate 2017-2022
Chart Global Biologics and Biosimilars Sales Volume (Units) and Growth Rate 2023-2028
Chart Global Biologics and Biosimilars Market Size (Million $) and Growth Rate 2023-2028
Table Global Biologics and Biosimilars Market Overview by Region
Table Global Biologics and Biosimilars Market Overview by Type
Table Global Biologics and Biosimilars Market Overview by Application
Chart 2017-2022 Global Manufacturer Biologics and Biosimilars Sales Volume (Units)
Chart 2017-2022 Global Manufacturer Biologics and Biosimilars Sales Volume Share
Chart 2017-2022 Global Manufacturer Biologics and Biosimilars Business Revenue (Million USD)
Chart 2017-2022 Global Manufacturer Biologics and Biosimilars Business Revenue Share
Chart 2017-2022 Global Manufacturer Biologics and Biosimilars Business Price (USD/Unit)
Chart Roche Biologics and Biosimilars Sales Volume, Price, Revenue and Gross margin 2017-2022
Chart Roche Biologics and Biosimilars Business Distribution
Chart Roche Interview Record (Partly)
Chart Roche Biologics and Biosimilars Business Profile
Table Roche Biologics and Biosimilars Product Specification
…
…
Chart United States Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart United States Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Canada Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Canada Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Mexico Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Mexico Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Brazil Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Brazil Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Argentina Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Argentina Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart China Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart China Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Japan Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Japan Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart India Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart India Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Korea Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Korea Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Southeast Asia Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Southeast Asia Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Germany Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Germany Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart UK Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart UK Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart France Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart France Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Spain Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Spain Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Russia Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Russia Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Italy Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Italy Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Middle East Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Middle East Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart South Africa Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart South Africa Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Egypt Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Egypt Biologics and Biosimilars Sales Price (USD/Unit) 2017-2022
Chart Global Biologics and Biosimilars Market Segment Sales Volume (Units) by Region 2017-2022
Chart Global Biologics and Biosimilars Market Segment Sales Volume (Units) Share by Region 2017-2022
Chart Global Biologics and Biosimilars Market Segment Market size (Million $) by Region 2017-2022
Chart Global Biologics and Biosimilars Market Segment Market size (Million $) Share by Region 2017-2022
Chart Global Biologics and Biosimilars Market Segment Sales Volume (Units) by Country 2017-2022
Chart Global Biologics and Biosimilars Market Segment Sales Volume (Units) Share by Country 2017-2022
Chart Global Biologics and Biosimilars Market Segment Market size (Million $) by Country 2017-2022
Chart Global Biologics and Biosimilars Market Segment Market size (Million $) Share by Country 2017-2022
Chart Monoclonal Antibodies Product Figure
Chart Monoclonal Antibodies Product Description
Chart Interferon Product Figure
Chart Interferon Product Description
Chart Erythropoietin Product Figure
Chart Erythropoietin Product Description
Chart Insulin Product Figure
Chart Insulin Product Description
Chart Vaccines Product Figure
Chart Vaccines Product Description
Chart Biologics and Biosimilars Sales Volume by Type (Units) 2017-2022
Chart Biologics and Biosimilars Sales Volume (Units) Share by Type
Chart Biologics and Biosimilars Market Size by Type (Million $) 2017-2022
Chart Biologics and Biosimilars Market Size (Million $) Share by Type
Chart Different Biologics and Biosimilars Product Type Price (USD/Unit) 2017-2022
Chart Biologics and Biosimilars Sales Volume by Application (Units) 2017-2022
Chart Biologics and Biosimilars Sales Volume (Units) Share by Application
Chart Biologics and Biosimilars Market Size by Application (Million $) 2017-2022
Chart Biologics and Biosimilars Market Size (Million $) Share by Application
Chart Biologics and Biosimilars Price in Different Application Field 2017-2022
Chart Global Biologics and Biosimilars Market Segment (By Channel) Sales Volume (Units) 2017-2022
Chart Global Biologics and Biosimilars Market Segment (By Channel) Share 2017-2022
Chart Biologics and Biosimilars Segment Market Sales Volume (Units) Forecast (by Region) 2023-2028
Chart Biologics and Biosimilars Segment Market Sales Volume Forecast (By Region) Share 2023-2028
Chart Biologics and Biosimilars Segment Market Size (Million USD) Forecast (By Region) 2023-2028
Chart Biologics and Biosimilars Segment Market Size Forecast (By Region) Share 2023-2028
Chart Biologics and Biosimilars Market Segment (By Type) Volume (Units) 2023-2028
Chart Biologics and Biosimilars Market Segment (By Type) Volume (Units) Share 2023-2028
Chart Biologics and Biosimilars Market Segment (By Type) Market Size (Million $) 2023-2028
Chart Biologics and Biosimilars Market Segment (By Type) Market Size (Million $) 2023-2028
Chart Biologics and Biosimilars Market Segment (By Application) Market Size (Volume) 2023-2028
Chart Biologics and Biosimilars Market Segment (By Application) Market Size (Volume) Share 2023-2028
Chart Biologics and Biosimilars Market Segment (By Application) Market Size (Value) 2023-2028
Chart Biologics and Biosimilars Market Segment (By Application) Market Size (Value) Share 2023-2028
Chart Global Biologics and Biosimilars Market Segment (By Channel) Sales Volume (Units) 2023-2028
Chart Global Biologics and Biosimilars Market Segment (By Channel) Share 2023-2028
Chart Global Biologics and Biosimilars Price Forecast 2023-2028
Chart Tumor Customers
Chart Diabetes Customers
Chart Cardiovascular Customers
Chart Hemophilia Customers
Summary:
Get latest Market Research Reports on Biologics and Biosimilars
. Industry analysis & Market Report on Biologics and Biosimilars
is a syndicated market report, published as Global Biologics and Biosimilars Market Status, Trends and COVID-19 Impact Report 2022
. It is complete Research Study and Industry Analysis of Biologics and Biosimilars
market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
